<- Go Home
Cholestech Corporation
Cholestech Corporation was acquired by Alere Inc. Cholestech Corporation manufactures and distributes diagnostic tools and point-of-care testing applications for immediate risk assessment and therapeutic monitoring of heart disease, inflammatory disorders, and diabetes. Its products include Cholestech LDX system that provides results for lipids, glucose, liver enzymes, and high sensitivity C-reactive protein at the point-of-care; Cholestech GDX, an A1C testing system that enables to monitor HbA1c levels as a measure of long-term glycemic control with a finger stick test. The company was founded in 1988 and is based in San Diego, California.
Market Cap
$330.3M
Volume
146.2K
Cash and Equivalents
$7.6M
EBITDA
$14.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$47.0M
Profit Margin
66.38%
52 Week High
$23.16
52 Week Low
$11.80
Dividend
N/A
Price / Book Value
3.38
Price / Earnings
33.66
Price / Tangible Book Value
3.40
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$12.1M
Return on Equity
11.31%
Return on Assets
8.05
Cash and Short Term Investments
$50.2M
Debt
N/A
Equity
$97.5M
Revenue
$70.9M
Unlevered FCF
$9.2M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium